HO-1 in Bone Biology: Potential Therapeutic Strategies for Osteoporosis
Authors:
Open Access
- 30 November 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 9
Abstract
Osteoporosis is a prevalent bone disorder characterized by bone mass reduction and deterioration of bone microarchitecture leading to bone fragility and fracture risk. In recent decades, knowledge regarding the etiological mechanisms emphasizes that inflammation, oxidative stress and senescence of bone cells contribute to the development of osteoporosis. Studies have demonstrated that heme oxygenase 1 (HO-1), an inducible enzyme catalyzing heme degradation, exhibits anti-inflammatory, anti-oxidative stress and anti-apoptosis properties. Emerging evidence has revealed that HO-1 is critical in the maintenance of bone homeostasis, making HO-1 a potential target for osteoporosis treatment. In this Review, we aim to provide an introduction to current knowledge of HO-1 biology and its regulation, focusing specifically on its roles in bone homeostasis and osteoporosis. We also examine the potential of HO-1-based pharmacological therapeutics for osteoporosis and issues faced during clinical translation.Keywords
Funding Information
- National Natural Science Foundation of China (81771114)
- Sichuan Provincial Science and Technology Support Program (2020YFS0173)
This publication has 202 references indexed in Scilit:
- FoxO-Mediated Defense against Oxidative Stress in Osteoblasts Is Indispensable for Skeletal Homeostasis in MiceCell Metabolism, 2010
- HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineageBone, 2010
- Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiationJournal of Bone and Mineral Metabolism, 2009
- Oxidative stress in bone remodelling and diseaseTrends in Molecular Medicine, 2009
- Skeletal Involution by Age-associated Oxidative Stress and Its Acceleration by Loss of Sex SteroidsJournal of Biological Chemistry, 2007
- Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complicationsOsteoporosis International, 2007
- Nrf2 Neh5 domain is differentially utilized in the transactivation of cytoprotective genesBiochemical Journal, 2007
- Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formationProceedings of the National Academy of Sciences, 2006
- Heme: a versatile signaling molecule controlling the activities of diverse regulators ranging from transcription factors to MAP kinasesCell Research, 2006
- Osteoclast differentiation and activationNature, 2003